ANNOUNCING OUR REDEFINE HEALTH ACADEMY – SUPPORTING YOUR PURSUIT AND OPTIMIZATION OF SPECIALTY PHARMACY OPERATIONS.

Recent Articles

April 25, 2018

The Ongoing Debate of the 340B Drug Pricing Program

The 340B program has grown beyond its original intent and the lack of transparency about how hospitals are using their savings is of growing concern. In November 2017, CMS issued their Medicare Hospital Outpatient Prospective Payment System (OPPS) Final Rule for CY 2018 (82 FR 59216) which implemented a payment reduction for most covered outpatient […]

April 9, 2018

Highlights of CMS’ Final Rule Revising Medicare Advantage and Part D

On April 2, CMS published their final rule for contract year 2019 that revises regulations related to Medicare Advantage (MA) and the Prescription Drug Benefit Program (Part D). The primary focus of this rule is to implement provisions from the Comprehensive Addiction and Recovery Act (CARA) to help fight the opioid epidemic, implement provisions from the 21st Century Cures Act and […]

October 17, 2016

MACRA: What Value-Based Payment Means to Pharmacists

We all know healthcare is changing, and the driver for much of this change is the government. MACRA (Medicare Access and CHIP Reauthorization Act of 2015), the latest sweeping healthcare reform law from Congress, is being massaged by CMS, and while most believe it is the physician at the tip of the MACRA spear, it […]

Industry Insight

Read our latest specialty pharmacy insight report here.